Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody

Experimental Neurology

Volumn 150, Issue 2, 1998, Pages 337-338

  Tanaka, Masami ^a   Tanaka, Keiko ^b   Idezuka, Jiro ^b   Tsuji, Shoji ^b  

^a Natl West Niigata Central Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; Paraneoplastic neurologic syndromes; Purkinje cell; Tumor immunology

Indexed keywords

AUTOANTIBODY; RECOMBINANT PROTEIN;

ARTICLE; CEREBELLUM DEGENERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PURKINJE CELL;

EID: 0032052011     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6760     Document Type: Article

References (9)

1. Paeglia P., Chiodoni C., Rodolfo M., Colombo M. P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:1996;317-322.
2. Posner J. B., Davis F. A. Neurologic Complications of Cancer. 1995.
3. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J. Neuroimmunol. 60:1995;135-141.
4. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
5. Tanaka K., Tanaka M., Onodera O., Igarashi S., Miyatake T., Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J. Neurol. Sci. 127:1994;153-158.
6. Tanaka K., Tanaka M., Onodera O., Nakajima T., Yamazaki M., Miyatake T., Tsuji S. Long-term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration. J. Neurol. Neurosurg. Psychiatry. 58:1995;256-257.
7. Tanaka M., Nishizawa M., Inuzuka T., Baba H., Sato S., Miyatake T. Human natural killer cell activity is reduced by treatment of anti-myelin-associated glycoprotein (MAG) monoclonal mouse IgM antibody and complement. J. Neuroimmunol. 10:1985;115-127.
8. Tanaka M., Tanaka K., Onodera O., Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin. Neurol. Neurosurg. 97:1995;96-101.
9. Tanaka M., Tanaka K. HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody. Neurology. 47:1996;606-607.